Cargando…
Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
Leukocyte cell-derived chemotaxin 2 (LECT2), a multifunctional hepatokine, is involved in many pathological conditions. However, its role in atherosclerosis remains undefined. In this study, we administered vehicle or LECT2 to male Apoe(-/-) mice fed a Western diet for 15 weeks. Atherosclerotic lesi...
Autores principales: | He, Wen-Ming, Dai, Ting, Chen, Jiong, Wang, Jian-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680125/ https://www.ncbi.nlm.nih.gov/pubmed/31310065 http://dx.doi.org/10.24272/j.issn.2095-8137.2019.030 |
Ejemplares similares
-
Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis
por: Kulkarni, Uday, et al.
Publicado: (2015) -
Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
por: Yoo, Hye Jin, et al.
Publicado: (2017) -
The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential
por: Zhu, Ming-Hui, et al.
Publicado: (2023) -
Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice
por: Kikuchi, Akihiro, et al.
Publicado: (2020) -
Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report
por: Kaur, Gagandeep, et al.
Publicado: (2017)